⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GILD News
Gilead Sciences Inc
Aurora Therapeutics Launches to Realize Potential of Personalized Gene Editing for Millions of Patients with Rare Diseases
businesswire.com
GILD
RXRX
WORLDLINE : EGM results - Press release
globenewswire.com
JPM
BAC
WFC
MS
GS
AXP
PYPL
V
MA
CMCSA
T
VZ
IBM
ORCL
SAP
ACN
ADP
PAYX
FIS
FDS
EVO
PSFE
LCID
RIVN
NIO
XPEV
TSLA
GM
F
STLA
CRDO
ADBE
GOOG
AMZN
META
NVDA
INTC
AMD
QCOM
CRM
NFLX
DIS
CMG
MCD
SBUX
PEP
KO
PG
JNJ
PFE
MRK
ABBV
AMGN
GILD
BMY
LLY
UNH
CVS
XOM
CVX
SHEL
BABA
JD
PDD
NTES
BIDU
AMTD
CPT
CA
BP
Xilio Therapeutics Highlights Upcoming Milestones and Recent Corporate Updates
globenewswire.com
XLO
GILD
ABBV
Aronora Appoints Industry Leaders to Drive Next Phase of Growth
globenewswire.com
GILD
EXAS
RLMD
AbTherx and Red Queen Bio Partner on Therapeutic Antibody Discovery
accessnewswire.com
GILD
Psoriasis Market to Exhibit Growth at a CAGR of 1.7% During the Forecast Period (2025-2034), Owing to Continuous Innovation in Biologic Therapies and Approval of Oral Small Molecules | DelveInsight
prnewswire.com
TAK
JNJ
CANF
AMGN
ABBV
NVS
BMY
AZN
BHC
LLY
UCB
LEO
REGN
XBI
IBB
JAZZ
MRK
SNY
GILD
INCY
PFE
LULU
PRTH
DRH
BIIB
TEVA
ARCT
HRMY
CRSP
NTLA
EDIT
SNOW
DDOG
CRM
GOOG
MSFT
AAPL
AMZN
TSLA
NVDA
META
NFLX
DIS
CMCSA
VZ
T
KO
PEP
MCD
SBUX
HD
EXAS
ILMN
BNTX
MRNA
XOM
CVX
BA
CAT
GE
IBM
INTC
CSCO
ADBE
QCOM
AMAT
MU
ORCL
ACN
COST
WMT
TGT
LOW
HON
GD
LMT
RTX
BAX
ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
businesswire.com
RIGL
GILD
ARCX
TIGIT Inhibitors Drugs Clinical Trials & Global Market Opportunity Outlook 2026-2030 with Focus on US, China, South Korea, Australia, and Europe - ResearchAndMarkets.com
businesswire.com
GILD
MRK
CGEN
VIR
Biotechnology Instruments Market Projected to Reach US$ 141.70 Billion by 2035 | Astute Analytica
globenewswire.com
ILMN
TMO
BRKR
LLY
ONON
PACB
RGEN
QGEN
AMGN
BMY
GILD
NVO
ANTX
DTIL
AGNC
DHR
RAAP: Alternative Funding Programs Put Rare Patients in Jeopardy
prnewswire.com
GILD